Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 13.66 M12.97 M12.74 M12.76 M13.88 M 52.35 M Research & development ————— — Operating income 3.85 M-3.08 M1.12 M-56.37 M2.56 M -55.77 M Non-Operating Income, Total -1.9 M-3.05 M-2.25 M-1.74 M-2.13 M -9.17 M Interest expense, net of interest capitalized 2.73 M2.83 M3 M2.82 M2.72 M 11.37 M Non-Operating Income, excl. Interest Expenses -2.73 M-2.83 M-3 M-2.82 M-2.72 M -11.37 M Unusual income/expense 826 K-225 K748 K1.08 M596 K 2.2 M Pretax income 1.95 M-6.13 M-1.13 M-58.11 M435 K -64.94 M Equity in earnings ————— — Taxes 59 K592 K525 K-1.06 M585 K 646 K Non-controlling/minority interest 749 K615 K556 K605 K717 K 2.49 M After tax other income/expense 0-110 K——— — Net income before discontinued operations 1.14 M-7.33 M-2.21 M-57.66 M-867 K -68.08 M Discontinued operations ————— — Net income 1.14 M-7.33 M-2.21 M-57.66 M-867 K -68.08 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.14 M-7.33 M-2.21 M-57.66 M-867 K -68.08 M Basic earnings per share (Basic EPS) 0.06-0.36-0.11-2.87-0.04 -3.38 Diluted earnings per share (Diluted EPS) 0.06-0.36-0.11-2.87-0.04 -3.38 Average basic shares outstanding 19.98 M20.11 M20.23 M20.14 M20.24 M — Diluted shares outstanding 20.17 M20.11 M20.23 M20.14 M20.24 M — EBITDA 8.56 M2.37 M8.29 M-51.36 M6.91 M -33.78 M EBIT 3.85 M-3.08 M1.12 M-56.37 M2.56 M -55.77 M Cost of revenue 82.1 M91.98 M86.66 M93.46 M86.75 M 358.86 M Other cost of goods sold 82.1 M91.98 M86.66 M93.46 M86.75 M 358.86 M Depreciation & amortization (cash flow) 4.71 M5.45 M7.17 M5.01 M4.35 M 21.99 M